Finance Watch: Lyell Raises $425m As Eight Biopharmas Go Public In One Week
In Addition To US IPOs, CARsgen Went Public In Hong Kong
Public Company Edition: Eight drug developers launched initial public offerings in the US that grossed $1.46bn combined during the week of 14 to 18 June as biotechnology stock values increased. Also, C4 Therapeutics led recent follow-on offerings, raising $180.8m.
